Sarissa Capital Management LP 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-01 5:14 pm Purchase |
2021-02-26 | 13D | Ironwood Pharmaceuticals, Inc. IRWD |
Sarissa Capital Management LP | 14,927,844 9.300% |
14,927,844 (New Position) |
Filing |
| 2020-11-09 09:59 am Sale |
2020-11-05 | 13D | Ironwood Pharmaceuticals, Inc. IRWD |
Sarissa Capital Management LP | 0 0.000% |
-12,493,000 (Position Closed) |
Filing |